相关实验视频
Updated: Jan 8, 2026
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
在艾滋病毒感染者中检测结核病的FujiLAM测定:系统性审查和元分析
Behailu Taye1, Haile Tesfaye2, Gemechu Churiso3
1Department of Medical Laboratory Science, College of Medicine and Health Science, Dilla University, Dilla, Ethiopia. behailutaye096@gmail.com.
BMC infectious diseases
|December 13, 2025
概括
富士电影SILVAMP TB LAM (FujiLAM) 尿液测试显示,在艾滋病毒感染者 (PLHIV) 中诊断结核病 (TB) 的准确性很好. 在住院患者和CD4计数较低的患者中,敏感性更高.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 传染病研究 传染病研究
- 艾滋病毒/艾滋病研究研究
背景情况:
- 全球对快速,准确,非唾液治疗点 (PoC) 结核病 (TB) 诊断的需求,特别是在艾滋病毒感染者 (PLHIV) 中.
- 富士电影SILVAMP TB LAM (FujiLAM) 尿液脂原比诺曼酸测试显示出有希望的结果,但在不同研究中诊断性能不一致.
- 需要进行系统性审查和元分析,以确定富士拉姆在PLHIV中的综合诊断准确性.
研究的目的:
- 确定在PLHIV中结核病诊断的FujiLAM试验的综合灵敏度和特异性.
- 为了评估不同患者子组和FujiLAM版本的诊断性能变化.
主要方法:
- 在Scopus,PubMed,EMBASE和谷歌学者中系统地搜索文献,寻找评估FujiLAM在PLHIV中的研究.
- 包括使用2x2表数据的研究;使用QUADAS-2工具进行质量评估.
- 双变随机效应模型元分析与子组分析和出版偏差评估.
主要成果:
- 包含了13篇文章,共有5,819名参与者.
- 聚合灵敏度:63% (95% CI:55-71%);聚合特异性:90% (95% CI:86-92%);AUC:0.87 (95% CI:0.85-0.91%). 聚合灵敏度:63% (95% CI:55-71%);聚合特异性:90% (95% CI:86-92%); AUC:0.87 (95% CI:0.85-0.91%). 聚合特异性:90% (95% CI:86-92%); AUC:0.87 (95% CI:0.85-0.91%). 聚合特异性:90% (95% CI:86-92%); AUC:0.87 (95% CI:0.85-0.91%). 聚合特异性:0.87 (95% CI:0.85-0.91%).
- 在住院患者 (71%) 和具有CD4计数≤100细胞/μL (76%) 或≤200细胞/μL (74%) 的PLHIV患者中观察到更高的敏感性. 富士兰I (65%) 比富士兰II (56%) 更敏感.
结论:
- 富士LAM在PLHIV中表现出对结核病的良好诊断准确性,在特定子组中表现有显著差异.
- 在住院患者和CD4计数较低的人群中,较高的敏感性表明有针对性的实用性.
- 虽然FujiLAM II的灵敏度较低,但其高特异性和批量一致性是有利的;对艾滋病毒相关的EPTB和儿童需要进一步研究.
相关概念视频
01:26Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
01:28Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
01:29Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:31Pulmonary Tuberculosis III
890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
890